Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Moderna COVID-19 Boosters Show Preclinical Efficacy Versus South African Variant

14 Apr 2021

• By Joseph Haas

Moderna vaccine — Moderna's COVID-19 variant boosters show promise in preclinical study

Related Content

J&J COVID-19 Vaccine Pause Expected To Be Brief, But Subsequent Use May Be Restricted

14 Apr 2021

Coronavirus Update: Moderna’s Variant-Targeting Vaccine Moves Into Trial, J&J Looks Set For US Authorization

24 Feb 2021

Speculation Over Moderna Vaccine Deal With Tata, Wockhardt

27 Jan 2021

Coronavirus Update: J&J Vaccine On Pause Amid Reports Of Clots

14 Apr 2021

Regulators Reassure On AZ Vaccine Safety After Rare Side Effect Deemed Plausible

08 Apr 2021

Coronavirus Update: How Vaccines Stack Up Against Variants So Far

15 Mar 2021

Related Companies

Moderna, Inc.

Pfizer Inc.

BioNTech SE

Johnson & Johnson

Lonza Group AG

Catalent, Inc

Additional Topics

Coronavirus COVID-19 Business Strategies Companies Research & Development Infectious Diseases BioPharmaceutical

More from COVID-19

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.